Delivery Order SPE2DB20D3103-SPE2DB24FL3Z3
Award Date 10/23/23
Potential Completion Date 10/24/23
Potential Value $4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $1,317.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,562,181,703 units of Oseltamivir Phosphate 75 mg capsules, with an ultimate completion date of September 15, 2023. The contract is not designated with a set-aside requirement, indicating open competition. It is part of a larger Indefinite...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of oseltamivir phosphate 75 mg capsules. The $1,116.37 firm fixed-price contract has an ultimate completion date of January 17, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award, valued at $12,975.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,559,450,627 units of Oseltamivir Phosphate 75 mg capsules, which are used to treat influenza. The contract has an ultimate completion date of December 27, 2022 and is structured as a firm fixed-price delivery order. There is no set-aside designation, indicating the contract was awarded through...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Oseltamivir Phosphate 75 mg capsules, a medication used to treat influenza. The contract has a firm fixed price of $3,424.95 and an ultimate completion date of July 29, 2024. The contract is a delivery order and is not associated with a set-aside program. It is part of a larger Indefinite...
- This is a $5,791.10 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,475,116 units of 75 mg Oseltamivir Phosphate capsules, a medication used to treat influenza. The contract has a performance period through March 6, 2025 and was awarded on March 5, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999...
- This contract award, valued at $1,870.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,640,790 units of the drug Oseltamivir Phosphate 75 mg capsules in unit dose packaging. The contract does not have a set-aside designation, indicating open competition. It is a firm-fixed price delivery order with a performance period extending to December 9,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,041.06 firm fixed-price delivery order is for the supply of 4567341626 Oseltamivir Phosphate 75 mg capsules. The contract has an ultimate completion date of February 24, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a large pharmaceutical distributor. The $8,797.52 firm fixed-price delivery order is for the supply of 4,565,862,354 units of the antiviral medication Oseltamivir Phosphate 75 mg capsules. The contract has an ultimate completion date of September 19, 2024 and does not have a set-aside designation. Amerisourcebergen, through its Corporate Office division, is a major supplier of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Oseltamivir Phosphate 75 mg capsules. The Firm Fixed Price Delivery Order has a ceiling value of $2,635.20 and an ultimate completion date of November 15, 2022. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- This federal contract award, valued at $3,240.77, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Oseltamivir Phosphate 75mg capsules, a medication used for the treatment of influenza. The contract is a Firm Fixed Price Delivery Order with a completion date of January 29, 2025. It is not designated with any set-aside requirements, indicating open competition....